| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 10/31/2000 | US6139781 Chemiluminescent electron-rich aryl-substituted 1,2-dioxetanes |
| 10/31/2000 | US6139735 Immobilization of membrane receptor on HPLC |
| 10/31/2000 | US6139718 Measuring electrochemical signal by providing substantially discontinuous working electrode surfaces that detect flux of electrochemical signal in two or three directions relative to working electrode surface |
| 10/31/2000 | CA2160780C Cold-tolerant strains of rhizobium species |
| 10/27/2000 | CA2307108A1 Process for production of mammalian cell lines, produced cell lines and their uses |
| 10/27/2000 | CA2307104A1 Human myoblast cell lines and their uses |
| 10/26/2000 | WO2000063705A1 Apparatus and method for transferring small volumes of substances |
| 10/26/2000 | WO2000063703A1 Use of azetidinone compounds |
| 10/26/2000 | WO2000063702A1 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes |
| 10/26/2000 | WO2000063695A1 Encoding of microcarriers |
| 10/26/2000 | WO2000063694A1 Proteome mining |
| 10/26/2000 | WO2000063691A2 Method for detecting mismatches or mutations in nucleic acid |
| 10/26/2000 | WO2000063690A1 Enriched antigen-specific t-cells, and related therapeutic and prophylactic compositions and methods |
| 10/26/2000 | WO2000063685A1 Biosensor |
| 10/26/2000 | WO2000063668A1 Apparatus and methods for sample delivery |
| 10/26/2000 | WO2000063667A2 Methods for identifying modulators of n-type ion channel inactivation |
| 10/26/2000 | WO2000063444A2 Method for detecting hepatitis c virus with hybridomas |
| 10/26/2000 | WO2000063443A2 Nucleic acid fragments for the identification of dechlorinating bacteria |
| 10/26/2000 | WO2000063442A1 Method of scanning for improved dynamic range |
| 10/26/2000 | WO2000063441A2 Single nucleotide polymorphisms in mitochondrial genes that segregate with alzheimer's disease |
| 10/26/2000 | WO2000063440A2 Diagnostic standards for virus detection and quantification |
| 10/26/2000 | WO2000063439A2 Shot-gun sequencing and amplification without cloning |
| 10/26/2000 | WO2000063438A2 Method of classifying a thyroid carcinoma using differential gene expression |
| 10/26/2000 | WO2000063437A2 Detection of nucleic acid reactions on bead arrays |
| 10/26/2000 | WO2000063436A1 Disease reversing targets |
| 10/26/2000 | WO2000063435A2 Method of identifying toxic agents using differential gene expression |
| 10/26/2000 | WO2000063434A1 MinK-RELATED GENES, FORMATION OF POTASSIUM CHANNELS AND ASSOCIATION WITH CARDIAC ARRHYTHMIA |
| 10/26/2000 | WO2000063433A1 PHARMACOLOGICAL TARGETING OF mRNA CAP FORMATION |
| 10/26/2000 | WO2000063432A1 Method for obtaining a plant with a lasting resistance to a pathogen |
| 10/26/2000 | WO2000063431A1 Diagnostic method and kit for congenital adrenal hyperplasia |
| 10/26/2000 | WO2000063430A1 Diagnosis of a person's risk for developing atherosclerosis or diabetic retinopathy |
| 10/26/2000 | WO2000063429A2 Automatable rapid test for detecting cancers, on the basis of telomerase(htc) mrna and specific primers and probes |
| 10/26/2000 | WO2000063428A1 Method for determining the existence of a biological activity of microorganisms |
| 10/26/2000 | WO2000063427A2 Compound screening method |
| 10/26/2000 | WO2000063426A2 Compound screening methods |
| 10/26/2000 | WO2000063425A2 Compound assay using nematodes |
| 10/26/2000 | WO2000063423A2 Viral detection method using viral encoded enzymes and chemiluminescent substrates |
| 10/26/2000 | WO2000063422A2 Detection of biological warfare agents |
| 10/26/2000 | WO2000063420A2 Biological fluid assay methods |
| 10/26/2000 | WO2000063419A1 Combinatorial chemical library supports having indicia at coding positions and methods of use |
| 10/26/2000 | WO2000063393A1 Dsp-8 dual-specificity map kinase phosphatase |
| 10/26/2000 | WO2000063392A1 Novel tyrosine phosphatase |
| 10/26/2000 | WO2000063382A1 Genes and expression products from hematopoietic cells |
| 10/26/2000 | WO2000063380A1 Vascular endothelial cell growth factor variants and uses thereof |
| 10/26/2000 | WO2000063379A2 The p2x3 receptor, methods of altering p2x3 receptor activity and uses thereof |
| 10/26/2000 | WO2000063378A2 Zalpha13: a human secreted protein |
| 10/26/2000 | WO2000063372A1 Synthetic signalling molecules |
| 10/26/2000 | WO2000063371A1 Protease activated receptor 2 variants |
| 10/26/2000 | WO2000063370A2 Nucleic acids coding for novel truncated cart proteins, corresponding truncated cart polypeptides and their use for therapeutic and diagnostic purposes |
| 10/26/2000 | WO2000063367A1 A novel family of beta sub-unit proteins from a voltage-gated sodium channel, nucleic acids encoding them and therapeutic or diagnostic uses thereof |
| 10/26/2000 | WO2000063352A2 Human homologues of fused gene |
| 10/26/2000 | WO2000063351A2 Carbohydrate-modifying enzymes |
| 10/26/2000 | WO2000063230A2 49 human secreted proteins |
| 10/26/2000 | WO2000062931A1 The use of microfluidic systems in the electrochemical detection of target analytes |
| 10/26/2000 | WO2000062822A1 Method for eliminating legionella from a colonized aqueous flux by electropulsation, method for the treatment of an aqueous flux by electropulsation and use thereof in the elimination of legionella |
| 10/26/2000 | WO2000062809A1 Proliferation inhibitor for androgen-independent tumor |
| 10/26/2000 | WO2000062804A2 Identification of sortase gene |
| 10/26/2000 | WO2000062795A2 UTEROGLOBIN IN THE TREATMENT OF IgA MEDIATED AUTOIMMUNE DISORDERS |
| 10/26/2000 | WO2000062605A1 eNOS MUTATIONS USEFUL FOR GENE THERAPY AND THERAPEUTIC SCREENING |
| 10/26/2000 | WO2000040719A3 Tissue repair protein involved in orofacial clefting and uses thereof |
| 10/26/2000 | WO2000036143A3 Selecting animals for parentally imprinted traits |
| 10/26/2000 | WO2000036135A3 Screening methods based on the use of protein kinases |
| 10/26/2000 | WO2000034449A3 UDP-N- ACETYL GLUCOSAMINE: GALACTOSE-β1, 3-N- ACETYL GALACTOSAMINE- α-R/ N- ACETYL GLUCOSAMINE -β1, 3-N- ACETYL GALACTOSAMINE- α-R (GlcNAc TO GalNAc) β1,6-N- ACETYL GLUCOSAMINYL TRANSFERASE, C2/4GnT |
| 10/26/2000 | WO2000034294A3 Tumor necrosis factor receptor homologue-1 ('trh1') |
| 10/26/2000 | WO2000031299A3 Method for determining nucleotide sequences using arbitrary primers and low stringency |
| 10/26/2000 | WO2000029615A3 A whole-genome radiation hybrid map of the dog genome and use thereof for identifying genes of interest |
| 10/26/2000 | WO2000029611A3 Novel primers and probes for detecting hiv |
| 10/26/2000 | WO2000028045A3 Human hydrolase proteins |
| 10/26/2000 | WO2000026666A3 Multiple marker characterization of single cells |
| 10/26/2000 | WO2000026415A9 A method for genomic substractive hybridization |
| 10/26/2000 | WO2000026391A3 Trans-species transfer of apoptotic genes and transgenic plants developed thereby |
| 10/26/2000 | WO2000024924A3 Methods for screening protease variants for use in detergent compositions |
| 10/26/2000 | WO2000023800A9 Reagent composition and method for identification of reticulated cells |
| 10/26/2000 | WO2000023603A8 Methods of treatment of type 2 diabetes |
| 10/26/2000 | WO2000018795A3 Compositions and methods for wt1 specific immunotherapy |
| 10/26/2000 | WO2000013018B1 Support for a method for determining analytes and a method for producing the support |
| 10/26/2000 | WO2000007577A3 Phosphatidylcholine as a medicament for the protection of mucosa |
| 10/26/2000 | WO2000000632A9 Methods for generating highly diverse libraries |
| 10/26/2000 | DE19918141A1 Diagnosing transmissible spongiform encephalopathy, particularly before appearance of clinical symptoms, by detecting specific markers in blood cells |
| 10/26/2000 | DE19917955A1 Continuous monitoring of an aerobic environmental biotechnology process using a flow system comprises using microorganisms from the process itself |
| 10/26/2000 | CA2373359A1 Nucleic acids coding for novel truncated cart proteins, corresponding truncated cart polypeptides and their use for therapeutic and diagnostic purposes |
| 10/26/2000 | CA2371976A1 A novel family of beta sub-unit proteins from a voltage-gated sodium channel, nucleic acids encoding them and therapeutic or diagnostic uses thereof |
| 10/26/2000 | CA2370957A1 Novel diagnostic standards for virus detection and quantification |
| 10/26/2000 | CA2370947A1 Method of scanning for improved dynamic range |
| 10/26/2000 | CA2370945A1 Method of classifying a thyroid carcinoma using differential gene expression |
| 10/26/2000 | CA2370884A1 Single nucleotide polymorphisms in mitochondrial genes that segregate with alzheimer's disease |
| 10/26/2000 | CA2370879A1 The use of microfluidic systems in the electrochemical detection of target analytes |
| 10/26/2000 | CA2370659A1 The p2x3 receptor, methods of altering p2x3 receptor activity and uses thereof |
| 10/26/2000 | CA2370617A1 Dsp-8 dual-specificity map kinase phosphatase |
| 10/26/2000 | CA2370615A1 Methods for identifying modulators of n-type ion channel inactivation |
| 10/26/2000 | CA2370559A1 Detection of biological warfare agents |
| 10/26/2000 | CA2370520A1 Viral detection method using viral encoded enzymes and chemiluminescent substrates |
| 10/26/2000 | CA2370305A1 Automatable rapid test for detecting cancers, on the basis of telomerase(htc) mrna and specific primers and probes |
| 10/26/2000 | CA2370297A1 Biosensor |
| 10/26/2000 | CA2370272A1 Protease activated receptor 2 variants |
| 10/26/2000 | CA2370246A1 Vascular endothelial cell growth factor variants and uses thereof |
| 10/26/2000 | CA2369969A1 Method of identifying toxic agents using differential gene expression |
| 10/26/2000 | CA2369868A1 Proteome mining |
| 10/26/2000 | CA2369764A1 Enos mutations useful for gene therapy and therapeutic screening |
| 10/26/2000 | CA2369478A1 Compound screening methods |